TOP3A and pancreatic adenocarcinoma: For example, the copy number amplifications of TOP3A in PAAD associated with better prognosis compared with normal copy number and copy number deletions (Fig 4F), while the copy number amplifications and deletions of TOP2A in UCEC were associated with poor prognosis compared with normal copy number (S3D Fig).